| Properties | Conclusion a | |
|---|---|---|
| CMR | Carcinogenicity (C) | Heptamaloxyloglucan is not considered to be mutagenic, carcinogenic or toxic for reproduction according to points 3.6.2, 3.6.3 and 3.6.4 of Annex II of Regulation (EC) 1107/2009. |
| Mutagenicity (M) | ||
| Toxic for Reproduction (R) | ||
| Endocrine‐disrupting properties | Heptamaloxyloglucan is not considered to meet the criteria for endocrine disruption for humans and non‐target organisms according to points 3.6.5 and 3.8.2 of Annex II of Regulation No 1107/2009, as amended by Commission Regulation (EU) 2018/605. | |
| POP | Persistence | Heptamaloxyloglucan is not considered to be a persistent organic pollutant (POP) according to point 3.7.1 of Annex II of Regulation (EC) 1107/2009. |
| Bioaccumulation | ||
| Long‐range transport | ||
| PBT | Persistence | Heptamaloxyloglucan is not considered to be a persistent, bioaccumulative and toxic (PBT) substance according to point 3.7.2 of Annex II of Regulation (EC) 1107/2009. |
| Bioaccumulation | ||
| Toxicity | ||
| vPvB | Persistence | Heptamaloxyloglucan is not considered to be a very persistent, very bioaccumulative substance according to point 3.7.3 of Annex II of Regulation (EC) 1107/2009. |
| Bioaccumulation | ||
a
Origin of data to be included where applicable (e.g. EFSA, ECHA RAC, Regulation).